tirzepatide memory loss Could a diabetes drug be the key to stopping Alzheimer's? Retatrutide vs. Tirzepatide for Weight
Description
As of June 2026, the FDA is in a public comment period on a proposal to formally exclude semaglutide, tirzepatide, and liraglutide from the 503B Bulk Drug Substances List

GLP-1 increases preingestive satiation via hypothalamic circuits in mice and humans

Clinical studies often combine drug therapy with some lifestyle guidance

it's a normal part of the process

Side Effects Profile Side effects are predominantly gastrointestinal, with both medications sharing nausea, vomiting, diarrhea, constipation, abdominal pain, and decreased appetite, as outlined in Understanding the Side Effects of Semaglutide and Tirzepatide: A Comprehensive Guide for Patients

[8] [9] These reports may reflect coincidental associations or indirect mechanisms rather than direct drug effects
